New computational algorithms make it possible to build neural networks with many input nodes and many layers, and distinguish "deep learning" of these networks from previous work on artificial neural nets.
Molecular representation learning lays the foundation for drug discovery. However, existing methods suffer from poor out-of-distribution (OOD) generalization, particularly when data for training and testing originate from different environments.
It is unclear whether distributed errors alone are sufficient for synapses to make coordinated updates to learn complex, nonlinear reward-based learning tasks.
To leverage the complementary merits of both worlds, we propose BetterDepth to achieve geometrically correct affine-invariant MDE while capturing fine details.
Deep learning based neural decoding from stereotactic electroencephalography (sEEG) would likely benefit from scaling up both dataset and model size. To achieve this, combining data across multiple subjects is crucial.